Dyne Therapeutics Inc
General ticker "DYN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.8B
Dyne Therapeutics Inc follows the US Stock Market performance with the rate: 44.0%.
Estimated limits based on current volatility of 3.2%: low 23.64$, high 25.19$
Factors to consider:
- Current price 46.5% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.95$, 16.38$]
- 2024-12-30 to 2025-12-30 estimated range: [5.76$, 14.07$]
Financial Metrics affecting the DYN estimates:
- Negative: Non-GAAP EPS, $ of -3.94 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -21.39 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term DYN quotes
Long-term DYN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $150.03MM | $170.96MM | $242.16MM |
| Operating Income | $-150.03MM | $-170.96MM | $-242.16MM |
| Non-Operating Income | $1.47MM | $2.86MM | $6.22MM |
| Interest Expense | $0.00MM | $2.92MM | $0.00MM |
| R&D Expense | $121.31MM | $142.76MM | $210.76MM |
| Income(Loss) | $-148.56MM | $-168.10MM | $-235.94MM |
| Profit(Loss) | $-148.56MM | $-168.10MM | $-235.94MM |
| Stockholders Equity | $368.20MM | $252.36MM | $91.29MM |
| Assets | $425.66MM | $306.32MM | $165.08MM |
| Operating Cash Flow | $-119.56MM | $-153.65MM | $-188.16MM |
| Capital expenditure | $3.62MM | $3.07MM | $0.73MM |
| Investing Cash Flow | $-137.89MM | $87.20MM | $83.31MM |
| Financing Cash Flow | $157.82MM | $37.39MM | $54.32MM |
| Earnings Per Share* | $-2.93 | $-3.18 | $-3.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.